Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Dec 19, 2023

BUY
$6.3 - $8.39 $6,930 - $9,229
1,100 New
1,100 $8,000
Q1 2023

May 15, 2023

BUY
$6.3 - $8.39 $6,930 - $9,229
1,100 New
1,100 $9,000
Q1 2021

May 14, 2021

SELL
$14.69 - $42.57 $4,083 - $11,834
-278 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$12.88 - $19.47 $3,580 - $5,412
278 New
278 $5,000

Others Institutions Holding KALV

About KalVista Pharmaceuticals, Inc.


  • Ticker KALV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,602,000
  • Market Cap $214M
  • Description
  • KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...
More about KALV
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.